These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19301690)

  • 1. Is there a need to continue anticoagulation following "successful" atrial fibrillation ablation?
    Levitt HL; Toor SZ; Coplan NL
    Prev Cardiol; 2009; 12(1):39-42. PubMed ID: 19301690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
    Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
    Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
    Ad N; Henry L; Schlauch K; Holmes SD; Hunt S
    Ann Thorac Surg; 2010 Oct; 90(4):1257-62. PubMed ID: 20868824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.
    Schrickel JW; Linhart M; Bänsch D; Thomas D; Nickenig G
    Clin Res Cardiol; 2016 Feb; 105(2):95-105. PubMed ID: 26514352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
    Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation.
    Viles-Gonzalez JF; Mehta D
    Curr Cardiol Rep; 2011 Feb; 13(1):38-42. PubMed ID: 21057900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
    Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oral anticoagulant after catheter ablation for atrial fibrillation.
    Chew D; Piccini JP
    Europace; 2021 Aug; 23(8):1157-1165. PubMed ID: 33400774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary?
    Ha AC; Hindricks G; Birnie DH; Verma A
    Curr Opin Cardiol; 2015 Jan; 30(1):1-7. PubMed ID: 25389647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
    Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
    J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial.
    Verma A; Ha ACT; Kirchhof P; Hindricks G; Healey JS; Hill MD; Sharma M; Wyse DG; Champagne J; Essebag V; Wells G; Gupta D; Heidbuchel H; Sanders P; Birnie DH
    Am Heart J; 2018 Mar; 197():124-132. PubMed ID: 29447772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Long-Term Anticoagulation After Catheter Ablation of Atrial Fibrillation.
    Arias R; Leef G; Daimee U; Sivasambu B; Akhtar T; Marine JE; Berger R; Calkins H; Spragg D
    Am J Cardiol; 2020 Aug; 128():12-15. PubMed ID: 32650904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should surgical ablation for atrial fibrillation be performed in patients with a significantly enlarged left atrium?
    Ad N; Henry L; Hunt S; Holmes SD
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):236-41. PubMed ID: 24183909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Simon D; Steinberg BA; Hong SJ; Kowey PR; Reiffel JA; Naccarelli GV; Chang P; Gersh BJ; Peterson ED; Piccini JP;
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.